National Academy of Sciences | 150 Year Anniversary

Questions? Call 800-624-6242

| Items in cart [0]

The National Academies Press

PAPERBACK
price:$47.00
add to cart

Rights & Permissions

topleft topright

Evaluation of Biomarkers and Surrogate Endpoints in Chronic Disease (2010)
Board on Health Care Services (HCS)
Board on Health Sciences Policy (HSP)
Food and Nutrition Board (FNB)

Citation Manager

. "4 Case Studies." Evaluation of Biomarkers and Surrogate Endpoints in Chronic Disease. Washington, DC: The National Academies Press, 2010.

Please select a format:

BibTeX EndNote RefMan


Page
196
bottomleft bottomright

The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy.


Evaluation of Biomarkers and Surrogate Endpoints in Chronic Disease

Yamada, S., T. Gotoh, Y. Nakashima, K. Kayaba, S. Ishikawa, N. Nago, Y. Nakamura, Y. Itoh, and E. Kajii. 2001. Distribution of serum C-reactive protein and its association with atherosclerotic risk factors in a Japanese population: Jichi Medical School Cohort Study. American Journal of Epidemiology 153(12):1183–1190.

Yang, G. C., J. D. Goldberg, and P. X. Ye. 2003. Risk of malignancy in follicular neoplasms without nuclear atypia: Statistical analysis of 397 thyroidectomies. Endocrine Practice 9(6):510-516.

Yaron, G., A. Brill, O. Dashevsky, I. M. Yosef-Levi, E. Grad, H. D. Danenberg, and D. Varon. 2006. C-reactive protein promotes platelet adhesion to endothelial cells: A potential pathway in atherothrombosis. British Journal of Haematology 134(4):426–431.

Young, H., R. Baum, U. Cremerius, K. Herholz, O. Hoekstra, A. A. Lammertsma, J. Pruim, and P. Price. 1999. Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: Review and 1999 EORTC recommendations. European Organization for Research and Treatment of Cancer (EORTC) PET Study Group. European Journal of Cancer 35(13):1773–1782.

Yu, H. H., R. Joubran, M. Asmi, T. Law, A. Spencer, M. Jouma, and N. Rifai. 2000. Agreement among four homocysteine assays and results in patients with coronary atherosclerosis and controls. Clinical Chemistry 46(2):258–264.

Zacho, J., A. Tybjaerg-Hansen, J. S. Jensen, P. Grande, H. Sillesen, and B. G. Nordestgaard. 2008. Genetically elevated C-reactive protein and ischemic vascular disease. New England Journal of Medicine 359(1897–1908).

Zaninotto, M., M. M. Mion, E. Novello, S. Altinier, and M. Plebani. 2007. New biochemical markers: From bench to bedside. Clinica Chimica Acta 381(1):14–20.

Zethelius, B., N. Johnston, and P. Venge. 2006. Troponin I as a predictor of coronary heart disease and mortality in 70-year-old men: A community-based cohort study. Circulation 113(8):1071–1078.

Zhang, Y. X., W. K. Cliff, G. I. Schoefl, and G. Higgins. 1999. Coronary C-reactive protein distribution: Its relation to development of atherosclerosis. Atherosclerosis 145(2):375–379.

Page
196